PCN70 COST-EFFECTIVENESS OF ADHERENCE AND PERSISTENCE INTERVENTIONS FOR ADJUVANT TAMOXIFEN THERAPY

Value in Health ◽

10.1016/j.jval.2019.04.194 ◽

2019 ◽

Vol 22 ◽

pp. S68-S69

Author(s):

A.A. Asfaw ◽

B. Talon ◽

S. Wirth ◽

L.K. Sharp ◽

D. Touchette

Keyword(s):

Cost Effectiveness ◽

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Adjuvant Tamoxifen Therapy

Download Full-text

Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy

PharmacoEconomics ◽

10.2165/00019053-200624030-00004 ◽

2006 ◽

Vol 24 (3) ◽

pp. 237-250 ◽

Author(s):

Jonathan Karnon ◽

Thomas Delea ◽

Stephen R D Johnston ◽

Robert Smith ◽

Jane Brandman ◽

...

Keyword(s):

Cost Effectiveness ◽

Postmenopausal Women ◽

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Adjuvant Tamoxifen Therapy

Download Full-text

Ocular toxicity from standard does adjuvant tamoxifen therapy

European Journal of Cancer ◽

10.1016/s0959-8049(02)80433-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S133

Author(s):

M Morgan

Keyword(s):

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Ocular Toxicity ◽

Adjuvant Tamoxifen Therapy

Download Full-text

A Laboratory Model To Explain the Survival Advantage Observed in Patients Taking Adjuvant Tamoxifen Therapy

Adjuvant Therapy of Breast Cancer IV - Recent Results in Cancer Research ◽

10.1007/978-3-642-84745-5_4 ◽

1993 ◽

pp. 23-33 ◽

Author(s):

D. M. Wolf ◽

V. C. Jordan

Keyword(s):

Tamoxifen Therapy ◽

Survival Advantage ◽

Adjuvant Tamoxifen ◽

Laboratory Model ◽

Adjuvant Tamoxifen Therapy

Download Full-text

Second Cancers After Adjuvant Tamoxifen Therapy for Breast Cancer

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/88.12.832 ◽

1996 ◽

Vol 88 (12) ◽

pp. 832-835 ◽

Author(s):

R. E. Curtis ◽

J. D. Boice ◽

D. A. Shriner ◽

B. F. Hankey ◽

J. F. Fraumeni

Keyword(s):

Breast Cancer ◽

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Second Cancers ◽

Adjuvant Tamoxifen Therapy

Download Full-text

The duration of adjuvant tamoxifen therapy

Cancer Treatment and Research - Biological and Hormonal Therapies of Cancer ◽

10.1007/978-1-4615-6189-7_10 ◽

1998 ◽

pp. 181-193 ◽

Author(s):

Malcolm M. Bilimoria ◽

V. Craig Jordan

Keyword(s):

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Adjuvant Tamoxifen Therapy

Download Full-text

Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-0902-3 ◽

2010 ◽

Vol 122 (3) ◽

pp. 609-617 ◽

Author(s):

Bostjan Seruga ◽

Eitan Amir

Keyword(s):

Cytochrome P450 ◽

Meta Analysis ◽

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Cytochrome P450 2D6 ◽

P450 2D6 ◽

Adjuvant Tamoxifen Therapy

Download Full-text

A Rationale for the Reinitiation of Adjuvant Tamoxifen Therapy in Women Receiving Fewer than 5 Years of Therapy

Clinical Breast Cancer ◽

10.3816/cbc.2002.n.003 ◽

2002 ◽

Vol 2 (4) ◽

pp. 282-286 ◽

Author(s):

William J. Gradishar ◽

Richard Hellmund

Keyword(s):

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Adjuvant Tamoxifen Therapy

Download Full-text

Abstract P6-04-27: EBAG9 immunoreactivity is a potential prognostic factor for poor outcome of breast cancer patients with adjuvant tamoxifen therapy

10.1158/0008-5472.sabcs12-p6-04-27 ◽

2012 ◽

Author(s):

T Shigekawa ◽

N Ijichi ◽

K Ikeda ◽

T Miyazaki ◽

K Horie-Inoue ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Cancer Patients ◽

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Poor Outcome ◽

Potential Prognostic Factor ◽

Adjuvant Tamoxifen Therapy

Download Full-text

Abstract 3604: Significant effect of polymorphisms in CYP2D6 and DT-1 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients

10.1158/1538-7445.am10-3604 ◽

2010 ◽

Author(s):

Hitoshi Zembutsu ◽

Kazuma Kiyotani ◽

Taisei Mushiroda ◽

Chiyo K. Imamura ◽

Naoya Hosono ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Adjuvant Tamoxifen Therapy

Download Full-text

Abstract B031: Prediction of the clinical benefit of adjuvant tamoxifen therapy using Breast Cancer Index (HOXB13:IL17BR)

10.1158/1557-3125.advbc-b031 ◽

2013 ◽

Author(s):

Yi Zhang ◽

Brock E. Schroeder ◽

Piiha-Lotta Jerevall ◽

Olle Stal ◽

Dennis C. Sgroi ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Benefit ◽

Tamoxifen Therapy ◽

Adjuvant Tamoxifen ◽

Breast Cancer Index ◽

Adjuvant Tamoxifen Therapy

Download Full-text